Pathways in pulmonary arterial hypertension: the future is here
It is well established that the endothelin, nitric oxide and prostacyclin pathways play an important role in the development of pulmonary arterial hypertension (PAH). Indeed, the therapeutic options currently available for the management of PAH all act on one of these mechanistic pathways. However,...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
European Respiratory Society
2012-12-01
|
Series: | European Respiratory Review |
Subjects: | |
Online Access: | http://err.ersjournals.com/content/21/126/321.full.pdf+html |